Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a -11.651% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a) CCc1nnc(NC(=O)CSc2nnc(-c3ccccc3O)n2CC)s1
b) Cc1csc(=O)n1CCC(=O)OCC(=O)Nc1ccc(S(N)(=O)=O)cc1
c) Cc1cc(C)cc(NC(=S)NC2CC3CCCC(C2)N3C2CC2)c1
d) COCc1cc(N2CCOCC2)nc(SCc2ccc(Cl)cc2)n1
Answer: d. COCc1cc(N2CCOCC2)nc(SCc2ccc(Cl)cc2)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COCc1cc(N2CCOCC2)nc(SCc2ccc(Cl)cc2)n1
COCc1cc(N2CCOCC2)nc(SCc2ccc(Cl)cc2)n1
4-[2-[(4-chlorophenyl)methylsulfanyl]-6-(methoxymethyl)pyrimidin-4-yl]morpholine